ANDA 219207, held by Zhejiang Poly Pharm Co Ltd. Topiramate.
As of Nov 15, 2026, ANDA 219207 (Topiramate), held by Zhejiang Poly Pharm Co Ltd, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 29, 2026 | Original application | Tentative approval | None posted |
| Topiramate50MG · capsule, extended release | Topiramate | None (tentative approval) |
| Topiramate25MG · capsule, extended release | Topiramate | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters